Maven Income 1 Regulatory News (MIG1)

29 Mar 2006 15:28

Synexus Clinical Research PLC29 March 2006 SYNEXUS CLINICAL RESEARCH PLC 29 MARCH 2006 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company SYNEXUS CLINICAL RESEARCH PLC 2. Name of shareholder having a major interest MURRAY VCT 4 PLC 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 AS IN 2 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them SEE ADDITIONAL INFORMATION BELOW 5. Number of shares / amount of stock acquired N/A 6. Percentage of issued class N/A 7. Number of shares / amount of stock disposed 300,000 8. Percentage of issued class 1.32% 9. Class of security ORDINARY GBP0.10 SHARES 10. Date of transaction 24 MARCH 2006 11. Date company informed 28 MARCH 2006 12. Total holding following this notification 882,794 13. Total percentage holding of issued class following this notification 3.87% 14. Any additional information FIGURES BASED ON SHARES IN ISSUE OF 22,791,196. NOTIFICATION ISSUED BY ABERDEEN ASSET MANAGEMENT PLC. 15. Name of contact and telephone number for queries 16. Name and signature of authorised company official responsible for makingthis notification Date of notification 29 MARCH 2006 This information is provided by RNS The company news service from the London Stock Exchange